Cite
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau.
MLA
Starbuck, Kristen, et al. “Treatment of Ovarian Cancer by Targeting the Tumor Stem Cell-Associated Carbohydrate Antigen, Sialyl-Thomsen-Nouveau.” Oncotarget, vol. 9, no. 33, May 2018, pp. 23289–305. EBSCOhost, https://doi.org/10.18632/oncotarget.25289.
APA
Starbuck, K., Al-Alem, L., Eavarone, D. A., Hernandez, S. F., Bellio, C., Prendergast, J. M., Stein, J., Dransfield, D. T., Zarrella, B., Growdon, W. B., Behrens, J., Foster, R., & Rueda, B. R. (2018). Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. Oncotarget, 9(33), 23289–23305. https://doi.org/10.18632/oncotarget.25289
Chicago
Starbuck, Kristen, Linah Al-Alem, David A Eavarone, Silvia Fatima Hernandez, Chiara Bellio, Jillian M Prendergast, Jenna Stein, et al. 2018. “Treatment of Ovarian Cancer by Targeting the Tumor Stem Cell-Associated Carbohydrate Antigen, Sialyl-Thomsen-Nouveau.” Oncotarget 9 (33): 23289–305. doi:10.18632/oncotarget.25289.